MI
NEO icon

Markowski Investments’s NeoGenomics NEO Stock Holding History

Markowski Investments’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671 Buy
+46
New +$444 ﹤0.01% 587

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Markowski Investments's NEO Position: Q2 2026 in Review

Markowski Investments opened a new position in NeoGenomics (NEO) in Q2 2026: 46 shares worth $671. The stake represents ﹤0.01% of the portfolio and ranks #587 among its holdings.

197 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Markowski Investments held 46 shares of NeoGenomics worth $671 as of Q2 2026.
  • NeoGenomics was a new Markowski Investments position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Markowski Investments's portfolio in Q2 2026, its #587 holding.
  • 197 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.